ArticleMolecular and clinical oncology2020

Sustained virological response by direct-acting antivirals reduces the recurrence risk of hepatitis C-related hepatocellular carcinoma after curative treatment.

Kenji Imai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.